
Testosterone Enanthate
Testosterone Enanthate
- SKU
- 55150-336
- UPC
- 0355150336012
- Mfr
- Eugia US LLC
5 ml in 1 vial, multi-dose, 1 vial, multi-dose in 1 carton
$387.96
4 packs × $96.99 each
Minimum order: 4 packs. Each product is sold in quantities worth at least $300.00.
Controlled medicine — prescription required. Upload your prescription at checkout or email it to us after ordering. We ship once a pharmacist has checked it and confirmed it with your prescriber. How it works
Males Testosterone enanthate injection is indicated for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone.
- Strength
- Testosterone Enanthate 200 mg/mL
- Unit of measure
- Per mL
- Dosage form
- Injection, Solution
- Route
- Intramuscular
Pharmacologic class
- Androgen Receptor AgonistsMechanism
- AndrogenEstablished class
- AndrostanesChemical structure
- Brand name
- Testosterone Enanthate
- Generic name
- Testosterone Enanthate
- Manufacturer
- Eugia US LLC
- Product NDC (SKU)
- 55150-336
- UPC
- 0355150336012
- Active ingredients
- Testosterone Enanthate 200 mg/mL
- Unit of measure
- Per mL
- Dosage form
- Injection, Solution
- Route
- Intramuscular
- DEA schedule
- CIII
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application number
- ANDA212659
- Marketed since
- February 28, 2024
- Label revised
- June 12, 2026
| Package NDC | Description |
|---|---|
| 55150-336-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-336-01) / 5 mL in 1 VIAL, MULTI-DOSE |
Reading this NDC
55150-336-01
- 01Labeler code
- Eugia US LLC
- 02Product code
- Testosterone Enanthate, injection, solution
- 03Package code
- 1 vial, multi-dose in 1 carton (55150-336-01) / 5 ml in 1 vial, multi-dose
Males Testosterone enanthate injection is indicated for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone. Primary hypogonadism (congenital or acquired) – Testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, or orchidectomy. Hypogonadotropic hypogonadism (congenital or acquired) – Gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency, or pituitary-hypothalamic injury from tumors, trauma, or radiation. (Appropriate adrenal cortical and thyroid hormone replacement therapy are still necessary, however, and are actually of primary importance.) If the above conditions occur prior to puberty, androgen replacement therapy will be needed during the adolescent years for development of secondary sexual characteristics.
Prolonged androgen treatment will be required to maintain sexual characteristics in these and other males who develop testosterone deficiency after puberty. Safety and efficacy of testosterone enanthate injection in men with age-related hypogonadism have not been established. Delayed puberty – Testosterone enanthate injection may be used to stimulate puberty in carefully selected males with clearly delayed puberty.
These patients usually have a familial pattern of delayed puberty that is not secondary to a pathological disorder; puberty is expected to occur spontaneously at a relatively late date. Brief treatment with conservative doses may occasionally be justified in these patients if they do not respond to psychological support. The potential adverse effect on bone maturation should be discussed with the patient and parents prior to androgen administration.
An X-ray of the hand and wrist to determine bone age should be obtained every six months to assess the effect of treatment on the epiphyseal centers (see WARNINGS ). Females Metastatic mammary cancer – Testosterone enanthate injection may be used secondarily in women with advancing inoperable metastatic (skeletal) mammary cancer who are one to five years postmenopausal.
Primary goals of therapy in these women include ablation of the ovaries. Other methods of counteracting estrogen activity are adrenalectomy, hypophysectomy, and/or antiestrogen therapy. This treatment has also been used in premenopausal women with breast cancer who have benefited from oophorectomy and are considered to have a hormone-responsive tumor. Judgment concerning androgen therapy should be made by an oncologist with expertise in this field.
Read before you order

Low testosterone · 2 min read
Low testosterone: symptoms, causes and how it is diagnosed
The symptoms of low testosterone, why diagnosis needs two morning blood tests, and the causes doctors look for.

Low testosterone · 2 min read
Testosterone injections, gels and capsules compared
How testosterone cypionate, enanthate and undecanoate injections compare with gels and oral capsules, and how to choose.

Low testosterone · 2 min read
Testosterone therapy: monitoring, fertility and risks
Why testosterone therapy needs blood tests, how it affects fertility and red blood cells, and the side effects to report.
More in Low Testosterone
View all
Brand · Injection
Aveed
Testosterone Undecanoate 250 mg/mL
- SKU
- 67979-511
- Mfr
- Endo USA, Inc.
From $1,985.31Prescription required

Brand · Injection
Azmiro
Testosterone Cypionate 200 mg/mL
- SKU
- 24338-055
- Mfr
- Azurity Pharmaceuticals, Inc.
From $252.00Min. 2 packsPrescription required

Brand · Capsule
Jatenzo
Testosterone Undecanoate 158 mg/1
- SKU
- 69087-158
- Mfr
- TOLMAR Inc.
From $1,451.99Prescription required

Brand · Capsule
Kyzatrex
Testosterone Undecanoate 150 mg/1
- SKU
- 80603-103
- Mfr
- Marius Pharmaceuticals
From $298.96Min. 2 packsPrescription required